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ABSTRACT
CONTEXT AND OBJECTIVE: Subclinical thyroid dysfunction is very common in clinical practice and there is some evidence that it may be associated with 
cardiovascular disease. The aim here was to evaluate the frequencies of subclinical thyroid disease and risk factors for cardiovascular disease among 
women at a workplace, and to evaluate the association between subclinical thyroid disease and cardiovascular risk factors among them. 
DEsIgN AND sETTINg: Cross-sectional study on 314 women aged 40 years or over who were working at Universidade de São Paulo (USP). 
METhODs: All the women answered a questionnaire on sociodemographic characteristics and risk factors for cardiovascular disease and the Rose 
angina questionnaire. Anthropometric variables were measured and blood samples were analyzed for blood glucose, total cholesterol and fractions, high-
sensitivity C-reactive protein, thyroid-stimulating hormone (TSH), free thyroxine (free-T4) and anti-thyroperoxidase antibodies (anti-TPO). 
REsulTs: The frequencies of subclinical hypothyroidism and hyperthyroidism were, respectively, 7.3% and 5.1%. Women with subclinical thyroid disease 
presented higher levels of anti-TPO than did women with normal thyroid function (P = 0.01). There were no differences in sociodemographic factors 
and cardiovascular risk factors according to thyroid function status, except for greater sedentarism among the women with subclinical hypothyroidism. 
Restricting the comparison to women with subclinical hypothyroidism (TSH > 10 mIU/l) did not change the results. 
CONClusION: In this sample of women, there was no association between poor profile of cardiovascular risk factors and presence of subclinical thyroid 
disease that would justify screening at the workplace. 
RESUMO
CONTEXTO E OBJETIVO: A doença tireoidiana subclínica é muito frequente na prática clínica e há evidências que sugerem associação com doença 
cardiovascular. O objetivo foi estabelecer a frequência das doenças subclínicas da tireóide e de fatores de risco para doença cardiovascular em mulheres 
no local de trabalho, bem como avaliar a associação da doença tireoidiana subclínica com fatores de risco para doença cardiovascular nessas mulheres.
TIPO DE EsTuDO E lOCAl: Estudo transversal em 314 mulheres com 40 ou mais anos de idade que trabalham na Universidade de São Paulo.
MéTODOs: Todas as mulheres responderam a questionário sobre características sócio-demográficas, fatores de risco para doença cardiovascular, 
questionário de angina de Rose, e foram realizadas medidas antropométricas e colhido sangue para dosagem de glicemia, colesterol total e frações, 
proteína C ultra-sensível, hormônio tireotrópico (TSH), tiroxina-livre (TS-livre) e anticorpos anti-tireoperoxidase.
REsulTADOs: As frequências de hipotireoidismo subclínico e de hipertireoidismo subclínico foram respectivamente de 7,3% e 5,1%. Os níveis de 
anticorpos antiperoxidase foram mais elevados nas mulheres com doença subclínica da tireoide comparadas às mulheres com função tireoidiana normal 
(P = 0,01). Não houve nenhuma diferença estatisticamente significativa entre os fatores sociodemográficos e de risco para doença cardiovascular entre 
os grupos exceto pela maior presença de sedentarismo entre as mulheres com hipotireoidismo subclínico. Restringir a comparação somente às mulheres 
com hipotireoidismo subclínico (TSH > 10 mIU/l) não mudou os resultados. 
CONClusãO: Nesta amostra de mulheres, não houve nenhuma associação entre um perfil inadequado dos fatores de risco para doença cardiovascular 
e a presença de doença subclínica da tireóide que justificasse o rastreamento no local de trabalho.
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InTROdUCTIOn 
Subclinical thyroid dysfunction is a very common situation among 
middle-aged women.1-3 It is characterized by abnormal serum thyroid-
stimulating hormone (TSH) levels with normal free thyroxine (free-T4) 
levels. The prevalence of subclinical hypothyroidism varies from approx-
imately 5-6% among women of all ages to 10-17% among women over 
60 years of age1,4 and up to 21% among women over 74 years of age.2 
Most patients with subclinical hypothyroidism (74-87%) present serum 
TSH levels of between 5 and 10 mIU/l.2,5,6 
The causes of subclinical hypothyroidism are the same as the causes 
of overt thyroid disease. Nevertheless, some patients with TSH lev-
els above the upper limit of the reference range are euthyroid outli-
ers (a term applied to the 2.5% of individuals whose TSH values are 
above percentile 97.5 of euthyroid distribution), and thus do not rep-
resent cases of disease. A significant proportion of such patients also 
have only transient thyroid axis disorders or iatrogenic subclinical hy-
pothyroidism (undertreated overt hypothyroidism or overtreated overt 
hyperthyroidism).7 Only a small percentage of community-level indi-
viduals with subclinical hypothyroidism have real mild thyroid failure. 
There is controversy about the need to aggressively search for cas-
es of subclinical thyroid disorders, or even the need to undertake pop-
ulation-based screening.1,8-13 One possible reason for recommend-
ing such diagnostic procedures is the possibility of future complica-
tions like cardiovascular disease, neuropsychiatric symptoms or overt 
hypothyroidism.1,14 
Cardiovascular disease in cases of subclinical hypothyroidism may 
be a consequence of cardiac dysfunction,15-17 atherosclerotic disease18 
or high cholesterol.19,20 Although some studies have shown an associa-
tion between cardiovascular disease and subclinical hypothyroidism18,21 
or hyperthyroidism,22 other longitudinal studies did not show any 
association.23,24 One clear bias in some studies with positive findings 
was the inclusion of patients with a definitive diagnosis of thyroid dis-
ease (e.g. patients with overt hypothyroidism receiving inadequate doses 
of L-thyroxine, or after thyroidectomy or radioiodine therapy), and not 
subclinical hypothyroidism.
Regarding subclinical hyperthyroidism, the possible complications 
are cardiovascular disease, neuropsychiatric symptoms, reduced bone 
mineral density with possible fractures and overt hyperthyroidism.1,13 
Cardiovascular disease in subclinical hyperthyroidism can be caused by 
cardiac dysfunction15-17 or atrial fibrillation.25 
Even considering those evidences, a recent systematic review on 
subclinical thyroid dysfunction confirmed that most scientific/medical 
societies do not recommend screening for thyroid disease among gen-
eral populations.26
Compared with men, Brazilian women present a high burden 
of cardiovascular mortality, similar to that found in Eastern European 
countries.27,28 In addition to the most common risk factors associated with 
cardiovascular disease, such as hypertension, smoking, diabetes or dyslipi-
demia, other factors can also be considered to be primordial determinants 
of cardiovascular disease.29 It is very important to identify primordial risk 
factors in the workplace,30 social inequalities,31 genetic polymorphisms32 
and subclinical thyroid dysfunction, in order to be able to prevent them.
OBJECTIVE
The present study had the aim of making a cross-sectional evalu-
ation on the frequencies of subclinical thyroid disease and risk factors 
for cardiovascular disease among women of at least 40 years of age who 
agreed to be screened for subclinical thyroid dysfunction at the work-
place, in a country with high female cardiovascular mortality. The study 
had also the objetive of making an evaluation on the association be-
tween subclinical thyroid disease and cardiovascular risk factors among 
these women.
METhOdS
Subject characteristics 
All 736 women aged 40 years or over who were working in three 
units at Universidade de São Paulo (USP) were invited to participate in 
screening for subclinical thyroid dysfunction. Informed consent was ob-
tained from all these women. The study was also approved by the Ethics 
Committee of the University hospital. 
Sample size
We calculated the sample size for a cross-sectional study with a di-
chotomous variable (subclinical hypothyroidism: yes or no). The ingre-
dients for the sample size calculation were an expected proportion of 
0.10, total width of 0.10 (0.05 below and 0.05 above) and confidence 
level of 95%, thus giving a number of 138 women. We did the same 
for subclinical hyperthyroidism (yes or no) using an expected propor-
tion of 0.10, total width of 0.05 (0.025 below and 0.025 above) and 
confidence level of 95%, thus giving a number of 291 women. Taking 
the expected proportion of 40% acceptance of the invitation for screen-
ing (expectation based on studies with volunteers in the university), we 
invited 736 women working in three different units in the University 
of São Paulo.33 
data from questionnaire and anthropometric variables
All these women answered a specific questionnaire about sociode-
mographic characteristics and cardiovascular disease morbidity. Seden-
tary lifestyle was defined as exercising less than once a week. High blood 
pressure was evaluated both as a categorical variable (presence vs. ab-
sence of hypertension; presence of hypertension was defined as self-re-
ported based on medical information, hospital registers or current use 
of medication to treat hypertension) and as a continuous variable (mean 
systolic and diastolic blood pressure). Diabetes was defined as a cate-
gorical variable (presence versus absence of diabetes; presence of diabe-
tes was defined as self-reported based on medical information, hospital 
registers or current use of medication to treat diabetes). Hypercholester-
olemia was defined as a categorical variable (presence versus absence of 
hypercholesterolemia; presence of hypercholesterolemia was defined as 
self-reported based on medical information, hospital registers or current 
use of medication to treat hypercholesterolemia). Angina pectoris was 
evaluated by means of the Rose angina questionnaire.34 
The anthropometric measurements were made at the hospital us-
ing standardized techniques. Body mass index (BMI) was obtained 
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subclinical thyroid disease
hypothyroidism 
n = 23 (100%)
hyperthyroidism
n = 16 (100%)
TSH (mU/L)* 12.7 (23.0) 0.19 (0.14)
Free-T4 ng/dl* 1.0 (0.2) 1.1 (0.3)
TPO-AB (UI/ml)* 163.4 (275.8) 104.4 (170.3)
Presence of TPO-AB > 35 UI/ml 11 (47.8) 7 (43.8)
Associated cause
Autoimmune
Post-thyroidectomy or iodotherapy
Other causes
11 (45.8)
0
13 (52.2)
7 (43.8)
0
9 (56.3)
Table 1. Thyroid-stimulating hormone (TSH), free-T4 levels and the likely 
cause of thyroid dysfunction in all women with subclinical thyroid diseases
*mean (SD); TPO-AB = thyroperoxidase-autoantibodies.
by dividing the weight in kilograms by the square of height in me-
ters. Waist circumference was measured to the nearest one millime-
ter at the level of midway between the lowest rib margin and the il-
iac crest. 
We excluded from the study all women who had had any previous 
diagnosis or treatment for thyroid dysfunction. Subclinical hypothy-
roidism was defined as a TSH level > 4.0 mIU/l and a normal free thy-
roxine level (0.6-1.8 ng/dl); and subclinical hyperthyroidism was de-
fined as a TSH level < 0.45 mIU/l and a normal free thyroxine level. In 
our analysis of the association between high-sensitivity C-reactive pro-
tein (hsCRP) and thyroid status, we discarded all hsCRP values higher 
than 10 mg/l, since these values were probably related to active infection 
or systemic inflammatory disease.35
Blood samples
Blood samples were taken after a minimum of 12 hours of fast-
ing. Total cholesterol (TC) and triglycerides (TG) were determined 
by means of an enzymatic colorimetric method. High-density li-
poprotein-cholesterol (HDL-C) was measured in the plasma after 
precipitation of the low-density lipoprotein-cholesterol (LDL-C), 
and fasting blood glucose was analyzed using an enzymatic meth-
od. LDL-C was calculated in accordance with the Friedewald equa-
tion. TSH concentration (reference range 0.3-4.0 mIU/l) was meas-
ured by means of a third-generation immunometric assay (Roche 
TSH, Basel, Swiss). Free thyroxine was determined using an enzyme 
immunoassay (reference range 0.6-1.8 ng/dl) (Roche Free-thyrox-
ine, Basel, Swiss) (sensitivity and specificity close to 100%). hsCRP 
was measured by means of particle-enhanced immunonephelometry 
(Dade Behring, hsCRP, Newark, USA) (sensitivity and specificity 
close to 100%). 
data analysis
For categorical variables, chi-square tests were used for comparisons 
when appropriate. For continuous variables, analysis of variance (ANO-
VA) with the Bonferroni post hoc evaluation test was used. The age-ad-
justed prevalence rate of subclinical hyperthyroidism and hypothyroid-
ism was calculated using a standard population from the World Health 
Organization. P values less than 0.05 were considered statistically sig-
nificant. The data were analyzed using the Statistical Package for the So-
cial Sciences (SPSS) 14.0.
RESUlTS
Out of the 736 women working in three units of USP who were 
invited to participate, 314 (42.7%) accepted the invitation and were in-
cluded in the study. Of these, three were excluded because of the pres-
ence of overt hyperthyroidism and 11 were excluded because of the 
presence of overt hypothyroidism. Between the women who agreed to 
participate and those who did not agree, the sociodemographic and clin-
ical characteristics were very similar, the frequencies of subclinical hy-
pothyroidism and hyperthyroidism were, respectively, 7.3% and 5.1%. 
Fifty-one women were positive for antibodies against thyroperoxidase 
(16.2%). The mean TSH level among the women with subclinical hy-
pothyroidism was 12.7 (± 23.0) mIU/l, but 78.3% of these women had 
TSH levels < 10 mIU/l.
Table 1 shows the mean values of TSH, free-T4 and anti-thyroper-
oxidase antibodies (anti-TPO), along with the likely causes of subclini-
cal thyroid disease in the sample. Almost 45% of the cases were attrib-
uted to autoimmune thyroid disease. Table 2 describes the general char-
acteristics and the distribution of cardiovascular risk factors according 
to thyroid status. The mean age was 47.6 (5.3) and the median was also 
47 years. Most of the women in the sample were between 40 and 50 
years old (only six were older than 60 years of age). There was no differ-
ence in general characteristics among these women except for sedentary 
lifestyle which was more common among the women with subclinical 
hypothyroidism.
There was no difference in the distribution of cardiovascular risk 
factors according to thyroid function status between the groups. Re-
stricting the comparison of subclinical hypothyroidism only to women 
with TSH levels higher than 10 mIU/l did not change the results except 
for the frequency of angina and the LDL levels. The frequency of an-
gina in the women with subclinical hypothyroidism was lower than in 
the women with subclinical hyperthyroidism and the women with nor-
mal thyroid function. Although a statistically significant difference was 
found, it was in the inverse direction, since we had expected a higher 
frequency of angina in women with subclinical thyroid disease, com-
pared with women with normal thyroid function. The same occurred 
for LDL-cholesterol, such that its levels were lower in individuals with 
subclinical hypothyroidism than in individuals with subclinical hyper-
thyroidism and normal thyroid function. Again, the results were in a 
direction that differed from what we would have expected if subclini-
cal thyroid disease were associated with a worse profile of cardiovascu-
lar risk factors. 
dISCUSSIOn
The frequencies of subclinical thyroid disease and anti-thyroperox-
idase antibodies were similar to those described in other countries, al-
though slightly higher for subclinical hyperthyroidism.1-3 There were no 
differences in the distribution of cardiovascular risk factors according to 
thyroid function status in this sample.
Surks et al. discussed the controversy regarding reference ranges 
for TSH and free-T4, in 2005.36 Using data from NHANES (National 
Health and Nutrition Examination Survey), in a disease-free popula-
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tion, the TSH values between percentile 2.5 and percentile 97.5 ranged 
from 0.45-4.17 mIU/l. Based on this data, we chose our cut-offs as < 
0.45 mIU/l and > 4.0 mIU/l.3 
The Whickham survey, which was a large, good-quality popula-
tion-based study with 20-year follow-up, the prevalence was 4% to 5% 
among women aged 18 to 44 years, and 8% to 10% among women age 
45 to 74 years. For subclinical hypothyroidism, our data were very simi-
lar to the data from the Whickham study, as cited in Helfand’s review in 
2004.1,36,37 In another study, the prevalence of subclinical hyperthyroid-
ism ranged from 0.8% to 2.5% among women over 60 years of age.38 
The difference between those results and ours can be explained partially 
by the lower cutoffs used in the earlier study. If we had only classified 
women with TSH < 0.2 mIU/l as cases of subclinical hyperthyroidism, 
we would have included only 9 women, thereby showing a frequency of 
2.8%, which would be closer to the previous results. 
Many authors have hypothesized an association between overt hy-
pothyroidism and cardiovascular disease, and several mechanisms may 
be implicated. For example, atherosclerosis may be associated with an 
adverse lipid profile or there may be a direct effect on myocardial or 
cardiovascular function.15 The relationship between subclinical thyroid 
dysfunction and cardiovascular disease could be mediated by the higher 
levels of serum lipids found in subclinical hypothyroidism. Some cross-
sectional studies have demonstrated that the serum levels of total choles-
terol and LDL-cholesterol are significantly higher in patients with sub-
clinical hypothyroidism than in euthyroid patients.39-42 However, other 
studies have shown non-statistically significant differences between the 
two groups23,40,41 or even lower total cholesterol levels18 in subclinical 
hypothyroid patients, compared with those with normal thyroid func-
tion. There have been more than 20 intervention trials assessing the ef-
fects of L-thyroxine on the lipid profile of subjects with subclinical hy-
pothyroidism, but most of them were uncontrolled. Many of these trials 
also involved iatrogenic subclinical hypothyroidism (e.g. patients taking 
inadequate doses of L-thyroxine) and individuals with a definitive diag-
nosis of thyroid disease. The studies20,42 that stratified TSH levels found 
nonsignificant effects in the patients with TSH < 10 mIU/l. 
In the present cross-sectional study, there were no differences in car-
diovascular risk factor profile between the women according to their 
thyroid function status. The sample included women who were more 
obese than the general population in Brazil, which is a country with an 
especially high risk of cardiovascular disease among women. Even for 
this sample of women with high levels of cardiovascular risk factors, we 
were unable to show any differences in cardiovascular risk according to 
thyroid function. Restricting the analysis to subclinical hypothyroidism 
among women with TSH > 10 mIU/l did not change the results.
Few studies have evaluated hsCRP, a non-classic cardiovascular risk 
factor among individuals with subclinical thyroid disease.39-44 Conflict-
ing results have been obtained in relation to hsCRP: three studies showed 
some correlation,44-46 while another three did not show any association 
at all.39,47,48 The positive studies tended to include patients with defini-
tive thyroid disease, as opposed to asymptomatic patients who had been 
found through screening. For example, the study by Christ-Crain et al.43 
compared 63 women with subclinical hypothyroidism with 61 women 
with overt hypothyroidism and 40 euthyroid controls, but more than 
40% of the women with subclinical hypothyroidism had been treated 
with radioiodine, surgery or anti-thyroid drugs for either for Graves 
disease or for toxic multinodular goiter. Among the remaining women 
with subclinical hypothyroidism, 90% had Hashimoto thyroiditis (i.e. 
positive for anti-thyroperoxidase antibodies). These patients are not an 
appropriate comparison group for community-dwelling cases of sub-
clinical hypothyroidism. In our study, we excluded from the subclinical 
hypothyroidism group any women who, despite their biochemical di-
agnosis of subclinical hypothyroidism (elevated TSH level with free-T4 
within the normal range), had already been diagnosed with thyroid dis-
ease or had been undergoing treatment with L-thyroxine.
The present study has several limitations. It is not a population-
based sample and, out of the 736 women invited to participate, only 
general characteristics and cardiovascular risk factors subclinical hyperthyroidism (n = 16) Normal thyroid function (n = 260) subclinical hyperthyroidism (n = 24) P
Age (years)* 49.0 (5.0) 47.6 (5.4) 47.0 (4.4) 0.68
Number of school years* 10.0 (2.5) 10.5 (2.5) 11.4 (1.7) 0.39
Frequency of anti-thyroperoxidase antibodies (%) 43.8 9.4 47.9 < 0.005
Presence of hypertension (%) 33.3 25.0 10.5 0.55
Presence of diabetes (%) 13.3 4.1 0 0.15
History of dyslipidemia (%) 26.7 29.0 22.2 0.89
Sedentary lifestyle (%) 50.0 53.7 88.9 0.01
Angina† (%) 16.7 7.7 22.2 0.09
Smoking (%) 21.4 19.0 5.3 0.26
Body mass index (kg/m2) 28.0 (5.5) 26.5 (4.5) 26.2 (4.2) 0.46
Waist circumference (cm) 92.6 (19.2) 85.4 (14.0) 80.4 (12.8) 0.09
Systolic blood pressure* (mm Hg) 120.6 (13.5) 123.8 (19.7) 122.9 (17.5) 0.82
Diastolic blood pressure* (mm Hg) 81.0 (8.1) 80.3 (10.9) 81.1 (11.3) 0.92
Fasting blood glucose* (mg/dl) 112.0 (46.5) 98.3 (27.3) 90.8 (7.8) 0.08
Total cholesterol* (mg/dl) 204.9 (46.7) 198.3 (34.2) 205.9 (46.6) 0.52
High-density lipoprotein-cholesterol* (mg/dl) 56.1 (12.4) 57.1 (13.0) 57.3 (12.9) 0.95
Low-density lipoprotein-cholesterol* (mg/dl) 125.7 (34.4) 118.0 (29.7) 116.2 (44.6) 0.60
High-sensitivity C-reactive protein (hsCRP)*‡ (mg/l) 2.7 (1.7) 2.1 (2.4) 2.5 (2.1) 0.82
Table 2. General characteristics and cardiovascular risk factors among women with subclinical or normal thyroid function
*mean (standard deviation); †Angina using Rose angina questionnaire; ‡hsCRP – ultra-sensitivity C-reactive protein ≥ 10 mg/l was excluded.
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42.7% agreed and were included. Although there were no sociodemo-
graphic differences between the women who agreed to participate and 
the women who did not, some kind of bias is still possible. However, 
this was a sample of high-risk women, in which a possible association 
between subclinical thyroid disease and an inadequate profile of car-
diovascular risk factors could easily be demonstrated. The results have 
implications for clinical practice, going against the notion of regular 
screening for subclinical thyroid diseases. 
COnClUSIOn
In this sample of women with high cardiovascular risk, subclinical 
thyroid disease did not show any association with an inadequate pro-
file of cardiovascular risk factors, except for sedentary lifestyle among 
the women with subclinical hyperthyroidism, compared with the oth-
er groups. The data from this study did not favor any recommenda-
tion for screening for thyroid function, as a regular practice in the 
workplace. 
REfEREnCES
1. Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction 
in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task 
Force. Ann Intern Med. 2004;140(2):128-41.
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence 
study. Arch Intern Med. 2000;160(4):526-34.
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies 
in the United States population (1988-1994): National Health and Nutrition Examination 
Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99.
4. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: 
an analysis of natural course and risk factors for the development of overt thyroid failure. J 
Clin Endocrinol Metab. 2004;89(10):4890-7.
5. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in 
the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 
1995;43(1)55-68.
6. Vanderpump M. Subclinical hypothyroidism: the case against treatment. Trends Endocrinol 
Metab. 2003;14(6):262-6.
7. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin 
Endocrinol Metab. 2001;86(10):4591-9.
8. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection 
of thyroid dysfunction. Arch Intern Med. 2000;160(11):1573-5.
9. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists 
medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism 
and hypothyroidism. Endocr Pract. 2002;8(6):457-69.
10. U.S. Department of Health & Human Services. Agengy for Healthcare Research and Quality. 
U.S. Preventive Services Task Force. Screening for thyroid disease. Available from: http://
www.ahrq.gov/clinic/uspstf/uspsthyr.htm. Accessed in 2009 (Dec 22).
11. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 
2001;345(4):260-5.
12. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001;345(7):512-6.
13. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guide-
lines for diagnosis and management. JAMA. 2004;291(2):228-38.
14. Cooper DS. Thyroid disease in the oldest old: the exception to the rule. JAMA. 
2004;292(21):2651-4.
15. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 
2001;344(7):501-9.
16. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M. Effect of thyroid hor-
mones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by 
positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab. 
2000;85(5):1822-7.
17. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the 
heart. Ann Intern Med. 2002;137(11):904-14.
18. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism 
is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: 
the Rotterdam Study. Ann Intern Med. 2000;132(4):270-8.
19. Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine 
therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of 
the literature. J Clin Endocrinol Metab. 2000;85(9):2993-3001.
20. Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol 
levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-con-
trolled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860-6.
21. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk of ischemic heart disease and all-cause 
mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89(7):3365-70.
22. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and 
cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year 
cohort study. Lancet. 2001;358(9285):861-5.
23. Vanderpump MP, Tunbridge WM, French JM, et al. The development of ischemic heart disease 
in relation to autoimmune thyroid disease in a 20-year follow-up study of an English com-
munity. Thyroid. 1996;6(3):155-60.
24. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid 
status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21): 
2591-9.
25. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for 
atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249-52.
26. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 
2008;29(1):76-131.
27. Lotufo PA. Mortalidade precoce por doenças do coração no Brasil. Comparação com outros 
países [Premature mortality from heart diseases in Brazil. A comparison with other coun-
tries]. Arq Bras Cardiol. 1998;70(5):321-5.
28. Lotufo PA. Non-communicable diseases in Brazil: mortality patterns, morbidity studies and 
risk factors. Arch Latinoam Nutr. 1997;47(2 Suppl 1):25-9. 
29. Stamler J, Fortmann SP, Levy RI, Prineas RJ, Tell G. Primordial prevention of cardiovascular 
disease risk factors: panel summary. Prev Med. 1999;29(6 Pt 2):S130-5.
30. Bosma H, Peter R, Siegrist J, Marmot M. Two alternative job stress models and the risk of 
coronary heart disease. Am J Public Health. 1998;88(1):68-74.
31. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the 
literature. Circulation. 1993;88(4 Pt 1):1973-98.
32. Murata M, Kawano K, Matsubara Y, Ishikawa K, Watanabe K, Ikeda Y. Genetic polymorphisms 
and risk of coronary artery disease. Semin Thromb Hemost. 1998;24(3):245-50.
33. Browner WS, Newman TB, Cummings SR, Hulley SB. Estimating sample size and power: the 
nitty-gritty. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB, editors. 
Designing clinical research. 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 2001. 
p. 65-94.
34. Luepker RV, Evans A, McKeigue P, Reddy KS. Cardiovascular survey methods. 3rd edition. 
Geneva: World Health Organization; 2004.
35. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular 
disease: application to clinical and public health practice: A statement for healthcare pro-
fessionals from the Centers for Disease Control and Prevention and the American Heart 
Association. Circulation. 2003;107(3):499-511.
36. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchan-
ged. J Clin Endocrinol Metab. 2005;90(9):5489-96. 
37. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the 
Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481-93.
38. Helfand M, Redfern CC. Clinical guideline, part 2. Screening for thyroid disease: an update. 
American College of Physicians. Ann Intern Med. 1998;129(2):144-58.
39. Efstathiadou Z, Bitsis S, Milionis HJ, et al. Lipid profile in subclinical hypothyroidism: is L-
thyroxine substitution beneficial? Eur J Endocrinol. 2001;145(6):705-10.
40. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: 
effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral 
target tissues. Am J Med. 1992;92(6):631-42.
41. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban 
community. J Am Geriatr Soc. 1999;47(6):703-9.
42. Kong WM, Sheikh MH, Lumb PJ, et al. A 6-month randomized trial of thyroxine treatment in 
women with mild subclinical hypothyroidism. Am J Med. 2002;112(5):348-54.
43. Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein and homocysteine 
values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, 
placebo-controlled trial. Atherosclerosis. 2003;166(2):379-86.
Frequency of subclinical thyroid dysfunction and risk factors for cardiovascular disease among women at a workplace 
Sao Paulo Med J. 2010; 128(1):18-23 23
44. Jublanc C, Bruckert E, Giral P, et al. Relationship of circulating C-reactive protein levels to 
thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxi-
ne is associated with elevated hsCRP. Atherosclerosis. 2004;172(1):7-11. 
45. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with 
a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease 
in males below 50 years. Clin Endocrinol (Oxf). 2004;61(2):232-8.
46. Pearce EN, Bogazzi F, Martino E, et al. The prevalence of elevated serum C-reactive pro-
tein levels in inflammatory and noninflammatory thyroid disease. Thyroid. 2003;13(7): 
643-8.
47. Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular 
risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 
2003;18(3):146-53.
48. Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in 
subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005;63(5):582-7.
Acknowledgement: We thank Dr Geraldo Medeiros Neto and Silvia Cardia for their help 
with thyroid test analyses
sources of Funding: Fundação de Amparo a Pesquisa do Estado de São Paulo (Fapesp 
01/14.970-4). Dr. Lotufo and Dr. Benseñor are recipients of a fellowship from the Conse-
lho Nacional de Pesquisa
Conflict of interest: Not declared
Date of first submission: February 11, 2009
last received: January 21, 2010
Accepted: January 21, 2010
Address for correspondence: 
Isabela Benseñor
Hospital Universitário (USP) — Centro de Pesquisa Clínica
Av. Lineu Prestes, 2.565 — 3o andar 
São Paulo (SP) — Brasil
CEP 05508-000
Tel. (+55 11) 3091-9300
Fax. (+55 11) 3091-9241
E-mail. isabensenor@hu.usp.br
